https://www.selleckchem.com/products/osmi-4.html
Deep brain stimulation (DBS) is a new treatment option for patients with therapy-resistant obsessive-compulsive disorder (OCD). Approximately 60% of patients benefit from DBS, which might be improved if a biomarker could identify patients who are likely to respond. Therefore, we evaluated the use of preoperative structural magnetic resonance imaging (MRI) in predicting treatment outcome for OCD patients on the group- and individual-level. In this retrospective study, we analyzed preoperative MRI data of a large cohort of patients who rec
Like
Comment
Share
